H.U. Group Holdings Inc
TSE:4544

Watchlist Manager
H.U. Group Holdings Inc Logo
H.U. Group Holdings Inc
TSE:4544
Watchlist
Price: 3 190 JPY 0.44% Market Closed
Market Cap: ¥183.4B

H.U. Group Holdings Inc
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

H.U. Group Holdings Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
H.U. Group Holdings Inc
TSE:4544
Income from Continuing Operations
¥5.5B
CAGR 3-Years
-38%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
E
Elan Corp
TSE:6099
Income from Continuing Operations
¥2.8B
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
23%
Solasto Corp
TSE:6197
Income from Continuing Operations
¥4.2B
CAGR 3-Years
13%
CAGR 5-Years
3%
CAGR 10-Years
N/A
BML Inc
TSE:4694
Income from Continuing Operations
¥7.8B
CAGR 3-Years
-31%
CAGR 5-Years
-4%
CAGR 10-Years
5%
France Bed Holdings Co Ltd
TSE:7840
Income from Continuing Operations
¥2.7B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
7%
Charm Care Corp
TSE:6062
Income from Continuing Operations
¥3.3B
CAGR 3-Years
2%
CAGR 5-Years
18%
CAGR 10-Years
45%
No Stocks Found

H.U. Group Holdings Inc
Glance View

Market Cap
183.4B JPY
Industry
Health Care

H.U.Group Holdings, Inc. provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. The company is headquartered in Shinjuku, Tokyo-To and currently employs 5,897 full-time employees. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The firm operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.

Intrinsic Value
4 050.36 JPY
Undervaluation 21%
Intrinsic Value
Price ¥3 190

See Also

What is H.U. Group Holdings Inc's Income from Continuing Operations?
Income from Continuing Operations
5.5B JPY

Based on the financial report for Dec 31, 2025, H.U. Group Holdings Inc's Income from Continuing Operations amounts to 5.5B JPY.

What is H.U. Group Holdings Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-10%

The average annual Income from Continuing Operations growth rates for H.U. Group Holdings Inc have been -38% over the past three years , -10% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett